Clinical Trial Update: Beta Blocker Interruption After Uncomplicated Myocardial Infarction [Phase 4]

View source ↗

Summary

Clinical trial update from a Phase 4 study evaluating interruption of beta-blocker therapy after uncomplicated myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED